Teva Pharmaceutical Industries (NYSE: TEVA)
Teva Pharmaceutical Industries Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Teva Pharmaceutical Industries Company Info
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
News & Analysis
What Is a Patent Cliff?
3 Bargain Stocks to Buy on the Dip
These stocks should be poised to rebound.
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
It's unclear whether the pivot will be enough to halt its recent decline.
Why Teva Pharmaceutical Stock Is Jumping Today
Investors are reacting positively to Teva's new growth strategy.
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
There's more to the concept of safety than having a business model that looks safe.
Better Generics Pharmaceutical Stock: Teva or Viatris?
Both have plans to return to growth.
Why Teva Pharmaceutical Stock Is Sliding Today
Investors were disappointed with the drugmaker's 2023 outlook.
6 Great Stocks to Buy in 2023 and Hold Forever
I own all six great businesses and don't plan to sell a single share.
Valuation
Earnings Transcripts
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
TEVA earnings call for the period ending December 31, 2023.
Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript
TEVA earnings call for the period ending September 30, 2023.
Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript
TEVA earnings call for the period ending June 30, 2023.
Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript
TEVA earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.